About
YHLO (Shenzhen YHLO Biotech Co., Ltd.) is a high-tech company based in Shenzhen, China, founded in 2008. It specializes in the research, development, production, and sales of in vitro diagnostic (IVD) instruments and supporting reagents, primarily utilizing chemiluminescence immunoassay (CLIA) technology. YHLO focuses on key healthcare areas such as autoimmune diseases, reproductive health, and infectious diseases, aiming to enhance healthcare quality through advanced technology. The company is publicly listed on the Shanghai Stock Exchange and recognized as a national high-tech enterprise. YHLO offers a variety of products, including the iFlash family of analyzers, biochemistry analyzers like the iBC 900, modular systems, and CLIA assays for various diseases. With a growing international presence, YHLO has established service and training centers in regions like Egypt and Japan, collaborating with partners to advance IVD technologies. Its customer base includes clinical laboratories, hospitals, and healthcare institutions worldwide, all seeking reliable diagnostic solutions.
Technologies
Keywords
Company Information
- Employees1800
- Founded2008
- Annual Revenue$275590000
Location
Shenzhen Shi, Guangdong Sheng, China
